| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.41 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.38 | 0.08 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.31 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.27 | 3e-12 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-12 |